Medical News: Nobel Prize, Cancer Therapy, and FDA Approvals

2025 Nobel Prize in Medicine

• 🏆 The 2025 Nobel Prize in Physiology or Medicine was jointly awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi.
• 🔬 Their discovery centered on regulatory T cells, which function as the immune system's "security guards" to prevent it from attacking healthy body tissues.
• 🧬 Sakaguchi first identified these crucial cells, and Brunkow and Ramsdell later pinpointed the FOXP3 gene as the master control for their development.
• 💡 This breakthrough has established the field of peripheral immune tolerance, offering new strategies to manipulate these cells for disease treatment.
• 🎯 Researchers are exploring boosting regulatory T cells for autoimmune diseases and inhibiting them to allow the immune system to fight cancer more effectively.

Innovative Cancer Therapy at UCLA

• 🚀 UCLA scientists have developed a novel "radiotheranostic" approach to detect and destroy aggressive, treatment-resistant cancers like osteosarcoma and glioblastoma.
• 🧪 This method uses an engineered antibody that targets a specific protein on aggressive cancer cells.
• ☢️ By attaching radioactive particles to this antibody, it enables precise tumor imaging and delivers targeted radiation directly to cancerous tissue.
• ✅ This highly focused therapy aims to spare healthy cells and potentially reduce the severe side effects associated with traditional radiation treatments.

Key FDA Approvals and Updates

• 💊 The FDA has approved an expanded use for the drug combination of lurbinectedin and atezolizumab for the maintenance treatment of extensive-stage small cell lung cancer.
• 👃 A decision is expected this month on a new use for tezepelumab (Tezspire) for chronic rhinosinusitis with nasal polyps, supported by positive Phase 3 trial data.
• 📈 These approvals provide new treatment options for patients, aiming to prevent disease progression and offer significant relief for chronic conditions.